Heron Therapeutics ' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives Nod

The FDA has approved Heron Therapeutics Inc’s HRTX supplemental New Drug Application for Zynrelef (bupivacaine and meloxicam) extended-release solution to expand the indication for soft tissue and orthopedic surgical procedures, including foot and ankle, and other procedures in which direct…#fda #zynrelef #heron #crosslink #vialaccessneedle #craigcollard #nda #hrtx
Source: Reuters: Health - Category: Consumer Health News Source Type: news